Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human p301l tau

Frontiers in Neurology

Volumn 5 MAR, Issue , 2014, Pages

  Sahara, Naruhiko ^a,b   Murayama, Miyuki ^b   Higuchi, Makoto ^a   Suhara, Tetsuya ^a   Takashima, Akihiko ^b,c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

P301L tau; Subcellular fractions; Synaptosomal fraction; Tau phosphorylation; Transgenic mice

Indexed keywords

TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; MALE; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TAUOPATHY; TRANSGENIC MOUSE;

EID: 84898026838     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00026     Document Type: Article

References (48)

1. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 24:1121-59. doi:10.1146/annurev.neuro.24.1.1121
2. Swaab DF, Dubelaar EJ, Hofman MA, Scherder EJ, Van Someren EJ, Verwer RW. Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res (2002) 138:343-73. doi:10.1016/S0079-6123(02)38086-5
3. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW. Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta (2005) 1739:216-23. doi:10.1016/j.bbadis.2004.08.014
4. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 41:17-24. doi:10.1002/ana.410410106
5. Goedert M, Spillantini MG. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim Biophys Acta (2000) 1502:110-21. doi:10.1016/S0925-4439(00)00037-5
6. Hutton M. Molecular genetics of chromosome 17 tauopathies. Ann N Y Acad Sci (2000) 920:63-73. doi:10.1111/j.1749-6632.2000.tb06906.x
7. Spillantini MG, Van Swieten JC, Goedert M. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics (2000) 2:193-205. doi:10.1007/s100489900084
8. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging (2001) 22:89-107. doi:10.1016/S0197-4580(00)00202-5
9. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science (2005) 309:476-81. doi:10.1126/science.1113694
10. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (2002) 103:26-35. doi:10.1007/s004010100423
11. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem (1993) 268:24374-84.
12. Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, Yue M, et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci (2007) 27:3650-62. doi:10.1523/JNEUROSCI.0587-07.2007
13. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, et al. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J (2012) 26:1946-59. doi:10.1096/fj.11-199851
14. Ren Y, Sahara N. Characteristics of tau oligomers. Front Neurol (2013) 4:102. doi:10.3389/fneur.2013.00102
15. Sahara N, Deture M, Ren Y, Ebrahim A-S, Kang D, Knight J, et al. Characteristics of TBS-extractable hyperphosphorylated Tau species: aggregation intermediates in rTg4510 mouse brain. J Alzheimers Dis (2013) 33:249-63. doi:10.3233/JAD-2012-121093
16. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron (2010) 68:1067-81. doi:10.1016/j.neuron.2010.11.030
17. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, Van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell (2010) 142:387-97. doi:10.1016/j.cell.2010.06.036
18. Zempel H, Thies E, Mandelkow E, Mandelkow EM. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci (2010) 30:11938-50. doi:10.1523/JNEUROSCI.2357-10.2010
19. Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, et al. The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease. J Neurosci (2012) 32:16857-71. doi:10.1523/JNEUROSCI.1858-12.2012
20. Kopeikina KJ, Polydoro M, Tai HC, Yaeger E, Carlson GA, Pitstick R, et al. Synaptic alterations in the rTg4510 mouse model of tauopathy. J Comp Neurol (2013) 521:1334-53. doi:10.1002/cne.23234
21. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, et al. Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci (2011) 31:700-11. doi:10.1523/JNEUROSCI.4152-10.2011
22. Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci (1999) 112(Pt 14):2355-67.
23. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol (1998) 143:777-94. doi:10.1083/jcb.143.3.777
24. Seitz A, Kojima H, Oiwa K, Mandelkow EM, Song YH, Mandelkow E. Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J (2002) 21:4896-905. doi:10.1093/emboj/cdf503
25. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol (2002) 156:1051-63. doi:10.1083/jcb.200108057
26. Santarella RA, Skiniotis G, Goldie KN, Tittmann P, Gross H, Mandelkow EM, et al. Surface-decoration of microtubules by human tau. J Mol Biol (2004) 339:539-53. doi:10.1016/j.jmb.2004.04.008
27. Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous system. J Cell Biol (1985) 101:1371-8. doi:10.1083/jcb.101.4.1371
28. Lewis J, Mcgowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 25:402-5. doi:10.1038/78078
29. Sahara N, Lewis J, Deture M, Mcgowan E, Dickson DW, Hutton M, et al. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J Neurochem (2002) 83:1498-508. doi:10.1046/j.1471-4159.2002.01241.x
30. Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, et al. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron (2000) 28:697-711. doi:10.1016/S0896-6273(00)00147-1
31. Kenessey A, Nacharaju P, Ko LW, Yen SH. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem (1997) 69:2026-38. doi:10.1046/j.1471-4159.1997.69052026.x
32. Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol (2007) 171:2012-20. doi:10.2353/ajpath.2007.070403
33. Takuma H, Arawaka S, Mori H. Isoforms changes of tau protein during development in various species. Brain Res Dev Brain Res (2003) 142:121-7. doi:10.1016/S0165-3806(03)00056-7
34. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci (2002) 22:9340-51.
35. Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, et al. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem (2005) 280:3963-73. doi:10.1074/jbc.M409876200
36. Peng I, Binder LI, Black MM. Biochemical and immunological analyses of cytoskeletal domains of neurons. J Cell Biol (1986) 102:252-62. doi:10.1083/jcb.102.1.252
37. Kosik KS, Finch EA. MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J Neurosci (1987) 7:3142-53.
38. Brion JP, Guilleminot J, Couchie D, Flament-Durand J, Nunez J. Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum. Neuroscience (1988) 25:139-46. doi:10.1016/0306-4522(88)90013-9
39. Mandell JW, Banker GA. The microtubule cytoskeleton and the development of neuronal polarity. Neurobiol Aging (1995) 16:229-37. doi:10.1016/0197-4580(94)00164-V discussion 238
40. Hirokawa N, Funakoshi T, Sato-Harada R, Kanai Y. Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons. J Cell Biol (1996) 132:667-79. doi:10.1083/jcb.132.4.667
41. Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, Cole GM, et al. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am J Pathol (2008) 172:1683-92. doi:10.2353/ajpath.2008.070829
42. Kanai Y, Hirokawa N. Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron (1995) 14:421-32. doi:10.1016/0896-6273(95)90298-8
43. Maas T, Eidenmuller J, Brandt R. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem (2000) 275:15733-40. doi:10.1074/jbc.M000389200
44. Reynolds CH, Garwood CJ, Wray S, Price C, Kellie S, Perera T, et al. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem (2008) 283:18177-86. doi:10.1074/jbc.M709715200
45. Gu J, Firestein BL, Zheng JQ. Microtubules in dendritic spine development. J Neurosci (2008) 28:12120-4. doi:10.1523/JNEUROSCI.2509-08.2008
46. Hu X, Viesselmann C, Nam S, Merriam E, Dent EW. Activity-dependent dynamic microtubule invasion of dendritic spines. J Neurosci (2008) 28:13094-105. doi:10.1523/JNEUROSCI.3074-08.2008
47. Jaworski J, Kapitein LC, Gouveia SM, Dortland BR, Wulf PS, Grigoriev I, et al. Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron (2009) 61:85-100. doi:10.1016/j.neuron.2008.11.013
48. Hayashi K, Suzuki A, Hirai S, Kurihara Y, Hoogenraad CC, Ohno S. Maintenance of dendritic spine morphology by partitioning-efective 1b through regulation of microtubule growth. J Neurosci (2011) 31:12094-103. doi:10.1523/JNEUROSCI.0751-11.2011